Anthony L Williams
Insider
First SEC filing: March 5, 2015 · Latest: March 5, 2015
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 7, 2019 | GMED | S | 37,826 | $46.01 | $1,740,374 | 0 Direct | -100.00% | Disposed | 64.3% (price as of 2026-10-02) |
| March 7, 2019 | GMED | M | 37,826 | · | · | 36,667 Direct | -50.78% | Disposed | (price as of 2026-10-02) |
| March 7, 2019 | GMED | M | 37,826 | $26.27 | $993,689 | 37,826 Direct | · | Acquired | 187.8% (price as of 2026-10-02) |
| March 6, 2019 | GMED | M | 5,507 | · | · | 74,493 Direct | -6.88% | Disposed | (price as of 2026-10-02) |
| March 6, 2019 | GMED | M | 2,879 | · | · | 56,667 Direct | -4.83% | Disposed | (price as of 2026-10-02) |
| March 6, 2019 | GMED | S | 8,386 | $46.14 | $386,930 | 0 Direct | -100.00% | Disposed | 63.8% (price as of 2026-10-02) |
| March 6, 2019 | GMED | M | 5,507 | $26.27 | $144,669 | 8,386 Direct | +191.28% | Acquired | 187.8% (price as of 2026-10-02) |
| March 6, 2019 | GMED | M | 2,879 | $43.77 | $126,014 | 2,879 Direct | · | Acquired | 72.7% (price as of 2026-10-02) |
| March 5, 2019 | GMED | M | 89,583 | · | · | 10,417 Direct | -89.58% | Disposed | (price as of 2026-10-02) |
| March 5, 2019 | GMED | M | 8,333 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 5, 2019 | GMED | M | 20,454 | · | · | 59,546 Direct | -25.57% | Disposed | (price as of 2026-10-02) |
| March 5, 2019 | GMED | M | 47,500 | · | · | 12,500 Direct | -79.17% | Disposed | (price as of 2026-10-02) |
| March 5, 2019 | GMED | S | 165,870 | $47.05 | $7,804,184 | 0 Direct | -100.00% | Disposed | 60.7% (price as of 2026-10-02) |
| March 5, 2019 | GMED | M | 8,333 | $24.10 | $200,825 | 165,870 Direct | +5.29% | Acquired | 213.7% (price as of 2026-10-02) |
| March 5, 2019 | GMED | M | 20,454 | $43.77 | $895,272 | 157,537 Direct | +14.92% | Acquired | 72.7% (price as of 2026-10-02) |
| March 5, 2019 | GMED | M | 47,500 | $25.52 | $1,212,200 | 137,083 Direct | +53.02% | Acquired | 196.2% (price as of 2026-10-02) |
| March 5, 2019 | GMED | M | 89,583 | $25.65 | $2,297,804 | 89,583 Direct | · | Acquired | 194.7% (price as of 2026-10-02) |
| Jan. 22, 2019 | GMED | A | 80,000 | · | · | 80,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 11, 2018 | GMED | M | 41,667 | · | · | 8,333 Direct | -83.33% | Disposed | (price as of 2026-10-02) |
| June 11, 2018 | GMED | M | 40,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 11, 2018 | GMED | M | 30,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 11, 2018 | GMED | M | 10,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 11, 2018 | GMED | S 10b5-1 | 1,400 | $56.87 | $79,618 | 0 Direct | -100.00% | Disposed | 32.9% (price as of 2026-10-02) |
| June 11, 2018 | GMED | S 10b5-1 | 120,267 | $56.14 | $6,751,789 | 1,400 Direct | -98.85% | Disposed | 34.7% (price as of 2026-10-02) |
| June 11, 2018 | GMED | M | 41,667 | $24.10 | $1,004,175 | 121,667 Direct | +52.08% | Acquired | 213.7% (price as of 2026-10-02) |
| June 11, 2018 | GMED | M | 40,000 | $24.42 | $976,800 | 80,000 Direct | +100.00% | Acquired | 209.6% (price as of 2026-10-02) |
| June 11, 2018 | GMED | M | 30,000 | $23.95 | $718,500 | 40,000 Direct | +300.00% | Acquired | 215.7% (price as of 2026-10-02) |
| June 11, 2018 | GMED | M | 10,000 | $13.04 | $130,400 | 10,000 Direct | · | Acquired | 479.8% (price as of 2026-10-02) |
| Jan. 22, 2018 | GMED | A | 80,000 | · | · | 80,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 13, 2017 | GMED | M | 15,000 | · | · | 10,000 Direct | -60.00% | Disposed | (price as of 2026-10-02) |
| Dec. 13, 2017 | GMED | S 10b5-1 | 15,000 | $38.30 | $574,500 | 0 Direct | -100.00% | Disposed | 97.4% (price as of 2026-10-02) |
| Dec. 13, 2017 | GMED | M | 15,000 | $13.04 | $195,600 | 15,000 Direct | · | Acquired | 479.8% (price as of 2026-10-02) |
| June 5, 2017 | GMED | M | 16,153 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 5, 2017 | GMED | S 10b5-1 | 16,153 | $31.94 | $515,927 | 0 Direct | -100.00% | Disposed | 136.7% (price as of 2026-10-02) |
| June 5, 2017 | GMED | M | 16,153 | $11.28 | $182,206 | 16,153 Direct | · | Acquired | 570.2% (price as of 2026-10-02) |
| Jan. 30, 2017 | GMED | A | 80,000 | · | · | 80,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 25, 2016 | GMED | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 7, 2015 | GMED | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 7, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $26.27 | Jan. 30, 2027 | 37,826 | Disposed |
| March 6, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $26.27 | Jan. 30, 2027 | 5,507 | Disposed |
| March 6, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.77 | Jan. 22, 2028 | 2,879 | Disposed |
| March 5, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $25.65 | July 7, 2025 | 89,583 | Disposed |
| March 5, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $24.10 | Jan. 20, 2025 | 8,333 | Disposed |
| March 5, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.77 | Jan. 22, 2028 | 20,454 | Disposed |
| March 5, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $25.52 | Jan. 25, 2026 | 47,500 | Disposed |
| Jan. 22, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.58 | Jan. 22, 2029 | 80,000 | Acquired |
| June 11, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $24.10 | Jan. 20, 2025 | 41,667 | Disposed |
| June 11, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $24.42 | June 23, 2024 | 40,000 | Disposed |
| June 11, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $23.95 | Jan. 23, 2024 | 30,000 | Disposed |
| June 11, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $13.04 | Jan. 24, 2023 | 10,000 | Disposed |
| Jan. 22, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.77 | Jan. 22, 2028 | 80,000 | Acquired |
| Dec. 13, 2017 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $13.04 | Jan. 24, 2023 | 15,000 | Disposed |
| June 5, 2017 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $11.28 | April 20, 2021 | 16,153 | Disposed |
| Jan. 30, 2017 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $26.27 | Jan. 30, 2027 | 80,000 | Acquired |
| Jan. 25, 2016 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $25.52 | Jan. 25, 2026 | 60,000 | Acquired |
| July 7, 2015 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $25.65 | July 7, 2025 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 5, 2015 | GMED | Stock Option (Right to Buy Class A Common Stock) | 16,153 | Direct |
| March 5, 2015 | GMED | Stock Option (Right to Buy Class A Common Stock) | 25,000 | Direct |
| March 5, 2015 | GMED | Stock Option (Right to Buy Class A Common Stock) | 30,000 | Direct |
| March 5, 2015 | GMED | Stock Option (Right to Buy Class A Common Stock) | 40,000 | Direct |
| March 5, 2015 | GMED | Stock Option (Right to Buy Class A Common Stock) | 50,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $393,382 | · | · | $1,054,268 | · | · | $12,592 | $1,460,242 |
| 2018 | $381,924 | · | · | $1,087,147 | $369,250 | · | $32,152 | $1,870,473 |
| 2017 | $370,800 | · | · | $666,149 | $369,250 | · | $32,064 | $1,438,263 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.